TGA posts overview on comments to proposed medtech reforms in Australia
This article was originally published in RAJ Devices
Australia's Therapeutic Goods Administration has posted on its website an overview of the 77 submissions it has received in response to a consultation on proposed reforms to the country's regulatory framework for medical devices1.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.